ICU Medical Inc.

NAS: ICUI

GO
/marketstate/country/us

Market open

 --Real time quotes

May 19, 2022, 12:13 p.m.

/zigman2/quotes/208026181/composite

$

183.02

Change

+3.76 +2.10%

Volume

Volume 44,426

Real time quotes

/zigman2/quotes/208026181/composite

Previous close

$ 179.25

$ 183.02

Change

+3.76 +2.10%

Day low

Day high

$176.76

$183.02

Open

52 week low

52 week high

$167.47

$282.00

Open

Annual Financials for ICU Medical Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 1.29B1.4B1.27B1.27B1.32B
Cost of Goods Sold (COGS) incl. D&A 867.4M830.76M795.26M810.3M837.86M
COGS excluding D&A 800.83M756.02M710.05M715.45M738.56M
Depreciation & Amortization Expense 66.57M74.74M85.21M94.85M99.29M
Depreciation 51.57M58.14M67.51M71.65M75.49M
Amortization of Intangibles 15M16.6M17.7M23.2M23.8M
Gross Income 425.21M569.29M470.95M460.71M478.45M
20172018201920202021 5-year trend
SG&A Expense 355.21M373.11M325.59M326.9M340.49M
Research & Development 51.25M52.87M48.61M42.95M47.5M
Other SG&A 303.95M320.25M276.98M283.95M-
Other Operating Expense -----
Unusual Expense 85.97M167.4M38.91M36.43M18.16M
EBIT after Unusual Expense (15.96M)28.77M106.44M97.37M119.8M
Non Operating Income/Expense 69.29M(11.06M)2.01M(1.83M)1.57M
Non-Operating Interest Income -5.37M6.8M3.7M2.8M
Equity in Affiliates (Pretax) -----
Interest Expense 2.05M709,000549,0001.75M980,000
Gross Interest Expense 2.05M709,000549,0001.75M980,000
Interest Capitalized -----
Pretax Income 51.28M22.37M114.71M97.49M123.19M
Income Tax (17.36M)(6.42M)13.67M10.62M20.05M
Income Tax - Current Domestic 5.04M2.36M9.38M8.45M24.09M
Income Tax - Current Foreign 3.17M9.14M7.99M7.29M7.24M
Income Tax - Deferred Domestic (25.5M)(12.19M)(7.05M)(7.17M)(9.97M)
Income Tax - Deferred Foreign (71,000)(5.72M)3.34M2.05M(1.31M)
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 68.64M28.79M101.04M86.87M103.14M
Minority Interest Expense -----
Net Income 68.64M28.79M101.04M86.87M103.14M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 68.64M28.79M101.04M86.87M103.14M
Preferred Dividends -----
Net Income Available to Common 68.64M28.79M101.04M86.87M103.14M
EPS (Basic) 3.501.414.904.164.86
Basic Shares Outstanding 19.61M20.39M20.63M20.91M21.21M
EPS (Diluted) 3.291.334.694.024.74
Diluted Shares Outstanding 20.86M21.6M21.55M21.59M21.78M
EBITDA 136.57M270.91M230.57M228.65M237.26M
Link to MarketWatch's Slice.